It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions associated with excess morbidity and mortality – – Obstructive ...

From sleep apnea-fighting mattresses to smart rings that play lullabies, the best sleep tech from Day 1 of CES 2025 ...

What many dismiss as a mere nighttime nuisance often signals deeper health issues requiring medical attention. While snoring ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

However, there is limited scientific evidence to support the chronic use of melatonin ... devices to treat obstructive sleep apnea specific antidepressants to treat insomnia dopamine agents ...

Zepbound (tirzepatide) is reshaping the competitive landscape in obesity treatment, challenging Novo Nordisk A/S' (NYSE:NVO) ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

Discover the evolving landscape of wellness in India, from traditional practices to specialized programs addressing modern ...

Pacific Pulmonary Medical Group (“PPMG”) filed a notice of data breach with the Attorney General of California after ...